We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
-13.57%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$84.5B
AUM Growth
-$745M
Cap. Flow
+$13.7B
Cap. Flow %
16.26%
Top 10 Hldgs %
10.97%
Holding
4,738
New
695
Increased
1,955
Reduced
1,481
Closed
562

Sector Composition

Rank Sector Weight
1 Healthcare 19.41%
2 Technology 16.8%
3 Consumer Staples 11.12%
4 Consumer Discretionary 10.11%
5 Financials 8.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NURO
3726
DELISTED
NeuroMetrix, Inc. Common Stock
NURO
$162K ﹤0.01%
5,514
+1,748
+46% +$52.2K
VGZ icon
3727
Vista Gold
VGZ
$251M
$161K ﹤0.01%
237,079
-260,107
-52% -$221K
TONX
3728
TON Strategy Co
TONX
$168M
$160K ﹤0.01%
38
+14
+58% +$62.8K
NEPT
3729
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
$160K ﹤0.01%
2,857
+2,735
+2,242% +$555K
IMPL
3730
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
$160K ﹤0.01%
17,200
-16,000
-48% -$117K
BRBS icon
3731
Blue Ridge Bankshares
BRBS
$315M
$159K ﹤0.01%
10,400
-37,650
-78% -$558K
TARA icon
3732
Protara Therapeutics
TARA
$220M
$159K ﹤0.01%
54,200
+16,600
+44% +$60.7K
LILM
3733
DELISTED
Lilium N.V. Class A Ordinary Shares
LILM
$159K ﹤0.01%
+67,200
New +$211K
HTGM
3734
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$159K ﹤0.01%
12,837
+8,211
+177% +$77K
WTER
3735
DELISTED
The Alkaline Water Company Inc. Common Stock
WTER
$158K ﹤0.01%
26,740
-3,833
-13% -$33.2K
CPS icon
3736
Cooper-Standard Automotive
CPS
$523M
$157K ﹤0.01%
31,500
-112,800
-78% -$658K
VIOT
3737
Viomi Technology
VIOT
$51.8M
$157K ﹤0.01%
91,164
+25,300
+38% +$40.8K
BRQS
3738
DELISTED
Borqs Technologies, Inc. Ordinary Shares
BRQS
$157K ﹤0.01%
7,815
+6,995
+853% +$274K
RAIL icon
3739
FreightCar America
RAIL
$261M
$156K ﹤0.01%
+42,830
New +$204K
HOOK
3740
DELISTED
HOOKIPA Pharma
HOOK
$154K ﹤0.01%
+9,470
New +$157K
EXAI
3741
DELISTED
Exscientia Plc American Depositary Shares
EXAI
$154K ﹤0.01%
+14,100
New +$168K
WULF icon
3742
TeraWulf
WULF
$8.75B
$153K ﹤0.01%
+127,246
New +$477K
DXYN
3743
DELISTED
Dixie Group Inc
DXYN
$153K ﹤0.01%
119,900
-26,500
-18% -$59.4K
OWLT icon
3744
Owlet
OWLT
$149M
$152K ﹤0.01%
6,379
+1,258
+25% +$62.3K
SQFT icon
3745
Presidio Property Trust
SQFT
$152K ﹤0.01%
4,755
-2,700
-36% -$90.8K
AIP icon
3746
Arteris
AIP
$1.38B
$151K ﹤0.01%
+21,700
New +$222K
WINT
3747
DELISTED
Windtree Therapeutics
WINT
$151K ﹤0.01%
8
+3
+60% +$88.4K
SFE
3748
DELISTED
Safeguard Scientifics, Inc.
SFE
$149K ﹤0.01%
39,934
-69,283
-63% -$289K
AMPS
3749
DELISTED
Altus Power
AMPS
$148K ﹤0.01%
+23,400
New +$156K
LOGC
3750
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
$147K ﹤0.01%
419,799
-39,400
-9% -$19.9K

Similar funds

Renaissance Technologies's Q2 2022 Portfolio in Review

As of Q2 2022, Renaissance Technologies held 4,738 positions worth $84.5B, down 0.87% from $85.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Renaissance Technologies deployed $13.7B of net new capital in Q2 2022, opening 695 new positions and adding to 1,955 existing holdings. Its largest new stake was Microsoft: 3,820,133 shares worth $981M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was Tesla, an estimated $661M trimmed.

  • Renaissance Technologies's largest Q2 2022 buy was Microsoft: 3,820,133 shares worth $981M.
  • Renaissance Technologies added most to Chevron in Q2 2022, an estimated $820M increase.
  • Renaissance Technologies's biggest Q2 2022 reduction was Tesla, cutting an estimated $661M.
  • Renaissance Technologies fully exited Amazon in Q2 2022, selling an estimated $675M.
  • Renaissance Technologies's ten largest holdings make up 11% of its $84.5B portfolio in Q2 2022.
  • Renaissance Technologies opened 695 new positions and closed 562 in Q2 2022.
  • Renaissance Technologies's portfolio value fell 0.87% quarter-over-quarter to $84.5B.

Based on Renaissance Technologies's 13F filing for Q2 2022, filed 12 Aug 2022.